Showing results (21-30 of 243) with videos related to
Sort By:
Pageof 25
AJR. American Journal of Roentgenology|June 16, 2016
Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal CancerJung Hoon Kim, Ijin Joo, Tae-Yong Kim, et al.Cancer Research and Treatment|October 30, 2015
Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal CancerMi-Seong Jeon, Sang-Hyun Song, Jiyeon Yun, et al.Molecular Carcinogenesis|April 2, 2010
KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approachYoung-Kwang Yoon, Hwang-Phill Kim, Sae-Won Han, et al.Materials (Basel, Switzerland)|August 10, 2017
Evaluation of Lapatinib Powder-Entrapped Biodegradable Polymeric Microstructures Fabricated by X-Ray Lithography for a Targeted and Sustained Drug Delivery SystemEun-Goo Jeong, Hyung Jung Yoo, Byeonghwa Song, et al.Experimental & Molecular Medicine|November 23, 2013
Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell lineYong Yook Lee, Hwang-Phill Kim, Min Jueng Kang, et al.Molecular Cancer Therapeutics|March 19, 2008
Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cellsHwang-Phill Kim, Sae-Won Han, Sung-Hak Kim, et al.Cancer Science|April 2, 2011
Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteinsKyung-Hun Lee, Ju-Hee Lee, Sae-Won Han, et al.The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2018
Incidence and Risk of Oxaliplatin-Induced Hypersensitivity in Patients with Asymptomatic Prior Exposure: A Prospective Observational StudyKyoung-Hee Sohn, Dong-Yoon Kang, Ju-Young Kim, et al.American Journal of Clinical Oncology|March 24, 2010
Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapyJi-Won Kim, Jeong-Ok Lee, Sae-Won Han, et al.Investigational New Drugs|July 2, 2011
Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancerJinah Park, Eunju Park, Sae-Won Han, et al.Pageof 25